Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Researchers Identify Mechanism Behind West Nile Virus-Associated Memory Loss

XTALKS VITALS NEWS

Neurons

The researchers identified sources of inflammation associated with the West Nile virus infection, which shorten the synapses responsible for transmitting messages between the neurons.

Share this!

June 24, 2016 | by Sarah Massey, M.Sc.

The mechanisms by which severe forms of West Nile virus cause mood disorders and memory loss, have been identified by researchers at the University of Colorado, Anschutz Medical Campus. The findings – which were published in the journal, Nature – could aid in the development of new treatments for the mosquito-transmitted infection.

Tweet: 50% of patients with #WestNilevirus experience #memoryloss http://ctt.ec/tabym+

According to the researchers, about half of all patients who survive a severe infection with West Nile virus, later experience learning problems, memory loss, difficulty concentrating and irritability. Until now, researchers were unclear as to how the virus caused these symptoms.

In their study, the researchers – including Dr. Bette K. DeMasters, head of neuropathology at the University of Colorado – found the virus does not have a cytotoxic effect on neurons. Instead, DeMasters and her colleagues identified sources of inflammation associated with the West Nile virus infection, which shorten the synapses responsible for transmitting messages between the neurons.

“What we found in mice, and later confirmed in humans, is that it’s not the death of cells that causes memory loss, it’s the loss of nerve cell connections,” said Dr. Kenneth Tyler, chairman of the department of neurology at the University of Colorado School of Medicine, and study co-author. “The viral infection activates microglial cells and complement pathways which are helping to fight the infection but in turn, end up destroying synapses.”



In mouse studies, the researchers noticed that West Nile virus-infected animals had more difficulty navigating their way through a maze, compared to healthy control mice. In analyzing the brain tissue collected from these infected mice, DeMasters and her team noted significant damage to the synapses in the brain.

This same phenomenon was found in brain tissue taken from humans who had died as a result of West Nile virus infection. Though relatively rare, West Nile virus is the number one cause of acute viral encephalitis in the US, according to Tyler. Individuals have a one in 100 chance of developing the severe form of the disease, once infected.

“This discovery opens up the opportunity to test therapies and medications on mice as a precursor to humans,” said Tyler. “We already have some drugs that might be good candidates for treating this condition.”


Keywords: West Nile Virus, Neurons, Memory Loss


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Amgen Identifies Issue with Patient Access to PCSK9 Inhibitor

March 23, 2017 - Most US patients hoping to get their PCSK9 inhibitor medications covered by their prescription drug plan are being denied, according to two new studied conducted by Amgen.

Featured In: Biotech News


Smartphone App Created Using Apple’s ResearchKit Used to Conduct Asthma Clinical Studies

March 22, 2017 - Researchers at the Icahn School of Medicine at Mount Sinai have conducted a large-scale, observational study of asthma patients using the Apple ResearchKit framework and the Asthma Health app on patients’ iPhones.

Featured In: Clinical Trials News


IBS Patients Taking Viberzi May Be at Increased Risk of Pancreatitis

March 22, 2017 - According to a recent drug safety communication issued by the US Food and Drug Administration (FDA), patients with irritable bowel syndrome (IBS) with diarrhea should not be treated using Viberzi (eluxadoline), if they do not have a gallbladder.

Featured In: Drug Safety News

LEAVE A COMMENT
 
  
THE XTALKS VITALS LIFE SCIENCE BLOG

Will Pharmaceutical Serialization Solve All of Our Drug Counterfeiting Problems?

REGISTER FOR THESE WEBINARS

How to Improve the Speed and Efficiency of Your Clinical Trials


High Performance Computing for High Content Screening - A Case Study


The FDA Guidance on the Assessment of Abuse Potential of Drug – A Critical Review


Treatment of Psoriasis: Improvements Through Clinical Trials


Copyright © 2016-2017 Honeycomb Worldwide Inc.